UCP2 and ischemia: Our data demonstrated that the genetic ablation of UCP2 significantly increased infarct volume and brain edema and caused more severe neurological deficit scores after ischemia/reperfusion in both normo- and hyperglycemic animals compared with WT mice subjected to the identical length of ischemia and reperfusion.